These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32178478)

  • 1. Gene Expression Alterations and Molecular Analysis of CHEK1 in Solid Tumors.
    Fadaka AO; Bakare OO; Sibuyi NRS; Klein A
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32178478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic analysis of gene expression alterations and clinical outcomes of STAT3 in cancer.
    Cui X; Jing X; Yi Q; Long C; Tan B; Li X; Chen X; Huang Y; Xiang Z; Tian J; Zhu J
    Oncotarget; 2018 Jan; 9(3):3198-3213. PubMed ID: 29423040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells.
    Gali-Muhtasib H; Kuester D; Mawrin C; Bajbouj K; Diestel A; Ocker M; Habold C; Foltzer-Jourdainne C; Schoenfeld P; Peters B; Diab-Assaf M; Pommrich U; Itani W; Lippert H; Roessner A; Schneider-Stock R
    Cancer Res; 2008 Jul; 68(14):5609-18. PubMed ID: 18632613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CHEK1 expression and inhibitors in TP53 mutant cancer].
    Õsz Á; Aszódi B; Vajda R; Keserû MG; Moll HP; Casanova E; Gyõrffy B
    Magy Onkol; 2019 Dec; 63(4):345-352. PubMed ID: 31821389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.
    Liu B; Qu J; Xu F; Guo Y; Wang Y; Yu H; Qian B
    Oncotarget; 2015 Apr; 6(11):9445-56. PubMed ID: 25840419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of CHEK1 in breast cancer: a high-throughput data analysis and immunohistochemical study.
    Wu M; Pang JS; Sun Q; Huang Y; Hou JY; Chen G; Zeng JJ; Feng ZB
    Int J Clin Exp Pathol; 2019; 12(1):1-20. PubMed ID: 31933717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients.
    Ebili HO; Iyawe VO; Adeleke KR; Salami BA; Banjo AA; Nolan C; Rakha E; Ellis I; Green A; Agboola AOJ
    Mol Diagn Ther; 2018 Feb; 22(1):79-90. PubMed ID: 29075961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multi-Omics Analysis of Bone Morphogenetic Protein 5 (
    Karim MA; Samad A; Adhikari UK; Kader MA; Kabir MM; Islam MA; Hasan MN
    Biomedicines; 2020 Jan; 8(2):. PubMed ID: 31973134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of the centromere protein-A(CENP-A)-encoding gene as a prognostic and predictive biomarker in human cancers.
    Sun X; Clermont PL; Jiao W; Helgason CD; Gout PW; Wang Y; Qu S
    Int J Cancer; 2016 Aug; 139(4):899-907. PubMed ID: 27062469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine/Threonine Kinase CHEK1-Dependent Transcriptional Regulation of RAD54L Promotes Proliferation and Radio Resistance in Glioblastoma.
    Bai X; Wang J; Huo L; Xie Y; Xie W; Xu G; Wang M
    Transl Oncol; 2018 Feb; 11(1):140-146. PubMed ID: 29287241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
    Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
    J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiling of microRNA target genes in colorectal cancer.
    Fadaka AO; Bakare OO; Pretorius A; Klein A
    Tumour Biol; 2020 Jun; 42(6):1010428320933512. PubMed ID: 32552466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
    Saha SK; Jeong Y; Cho S; Cho SG
    Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer.
    Xie S; Shen C; Tan M; Li M; Song X; Wang C
    Oncotarget; 2017 Apr; 8(16):27216-27239. PubMed ID: 28423713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
    Gao Z; Fu P; Yu Z; Zhen F; Gu Y
    Technol Cancer Res Treat; 2019; 18():1533033819853237. PubMed ID: 31159706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of gene expression alterations and clinical significance of the HECT domain-containing ubiquitin ligase HUWE1 in cancer.
    Su C; Wang T; Zhao J; Cheng J; Hou J
    Oncol Lett; 2019 Sep; 18(3):2292-2303. PubMed ID: 31404287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers.
    Harryman WL; Pond E; Singh P; Little AS; Eschbacher JM; Nagle RB; Cress AE
    Am J Transl Res; 2016; 8(2):940-54. PubMed ID: 27158381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.
    Yang X; Pan Y; Qiu Z; Du Z; Zhang Y; Fa P; Gorityala S; Ma S; Li S; Chen C; Wang H; Xu Y; Yan C; Ruth K; Ma Z; Zhang J
    Clin Cancer Res; 2018 Apr; 24(7):1629-1643. PubMed ID: 29326282
    [No Abstract]   [Full Text] [Related]  

  • 19. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of compensatory pro-survival and anti-apoptotic modulator, IKKε, sensitizes ovarian cancer cells to CHEK1 loss through an increased level of p21.
    Kim MK; Min DJ; Wright G; Goldlust I; Annunziata CM
    Oncotarget; 2014 Dec; 5(24):12788-802. PubMed ID: 25474241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.